C. Galluzzo

发表

HIV-exposed infants with EBV infection have a reduced persistence of the immune response to the HBV vaccine

M. Giuliano, R. Luhanga, G. Liotta, 2021, AIDS Research and Therapy.

Interindividual and Intra-Individual Variabilities of Darunavir and Ritonavir Plasma Trough Concentrations in Multidrug Experienced HIV Patients Receiving Salvage Regimens

D. Francisci, M. Regazzi, P. Villani, 2013, Therapeutic drug monitoring.

Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.

D. Francisci, L. Monno, R. Bucciardini, 2012, The Journal of antimicrobial chemotherapy.

Immunoglobulin G passive transfer from mothers to infants: total IgG, IgG subclasses and specific antipneumococcal IgG in 6-week Malawian infants exposed or unexposed to HIV

M. Giuliano, R. Luhanga, S. Orlando, 2022, BMC Infectious Diseases.

APOBEC3G/3A Expression in Human Immunodeficiency Virus Type 1-Infected Individuals Following Initiation of Antiretroviral Therapy Containing Cenicriviroc or Efavirenz

L. Fantuzzi, S. Vella, M. Gauzzi, 2018, Front. Immunol..

HIV-1 integrase inhibitors are substrates for the multidrug transporter MDR1-P-glycoprotein

A. Molinari, R. Di Santo, R. Costi, 2007, Retrovirology.

Markers of microbial translocation during pregnancy: differences among HIV+ women of African and European provenance.

M. Floridia, S. Baroncelli, M. Pirillo, 2020, Journal of infection in developing countries.

Microbial translocation and T cell activation are modified by direct‐acting antiviral therapy in HCV‐infected patients

L. Palmisano, M. Merli, G. Mennini, 2018, Alimentary pharmacology & therapeutics.

Antiretroviral resistance mutations in untreated pregnant women with HIV infection in Uganda and Rwanda.

M. Giuliano, S. Vella, J. Vyankandondera, 2007, AIDS research and human retroviruses.

The importance of testing genotypic resistance in proviral DNA of patients fully responding to highly active antiretroviral therapy.

L. Palmisano, M. Giuliano, C. Galluzzo, 2009, Journal of acquired immune deficiency syndromes.

Serum Phosphate and Creatinine Levels in the First Year of Life in Infants Born to HIV-Positive Mothers Receiving Tenofovir-Based Combination Regimens During Pregnancy and Prolonged Breastfeeding in an Option B+ Program in Malawi

S. Mancinelli, L. Palombi, M. Giuliano, 2016, Journal of acquired immune deficiency syndromes.

Antibodies against pneumococcal capsular polysaccharide in Malawian HIV-positive mothers and their HIV-exposed uninfected children

S. Mancinelli, L. Palombi, M. Giuliano, 2016, Infectious diseases.

Viral sequence analysis of HIV-positive women and their infected children: insight on the timing of infection and on the transmission network.

M. Ciccozzi, M. Mirra, A. Lo Presti, 2014, AIDS research and human retroviruses.

No Evidence of Autoimmune Disorders in Antiretroviral-Experienced HIV-1-Infected Individuals after Long-Term Treatment with Raltegravir

V. Vullo, L. Palmisano, D. Francisci, 2013, Antiviral therapy.

Raltegravir Plasma Concentrations in Treatment-Experienced Patients Receiving Salvage Regimens Based on Raltegravir with and without Maraviroc Coadministration

V. Vullo, D. Francisci, M. Regazzi, 2010, The Annals of pharmacotherapy.

Dynamics of immunoglobulin G subclasses during the first two years of life in Malawian infants born to HIV-positive mothers

M. Giuliano, R. Luhanga, G. Liotta, 2020, BMC Pediatrics.

Anti-Streptococcus pneumoniae and rotavirus IgG levels in HIV-positive women do not correlate with maternal status and infant morbidity and mortality.

S. Mancinelli, L. Palombi, M. Giuliano, 2015, Journal of medical microbiology.

Trough Concentrations of Lopinavir, Nelfinavir, and Nevirapine With Standard Dosing in Human Immunodeficiency Virus-Infected Pregnant Women Receiving 3-Drug Combination Regimens

E. Tamburrini, M. Regazzi, P. Villani, 2008, Therapeutic drug monitoring.

Dynamics of SARS-CoV-2 exposure in Malawian infants between February 2020 and May 2021

M. Giuliano, R. Luhanga, S. Orlando, 2022, Journal of Clinical Virology Plus.

Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action.

Y. Pommier, E. Novellino, A. Lavecchia, 2006, Journal of medicinal chemistry.

Novel Quinolinonyl Diketo Acid Derivatives as HIV-1 Integrase Inhibitors: Design, Synthesis, and Biological Activities

Y. Pommier, E. Novellino, A. Lavecchia, 2008, Journal of medicinal chemistry.

Reconstitution of Intestinal CD4 and Th17 T Cells in Antiretroviral Therapy Suppressed HIV-Infected Subjects: Implication for Residual Immune Activation from the Results of a Clinical Trial

E. N. Cavallari, G. d’Ettorre, V. Vullo, 2014, PloS one.

Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother‐to‐infant transmission in Malawi

S. Mancinelli, L. Palombi, M. Giuliano, 2012, Journal of medical virology.

Antiretroviral Prophylaxis for Breastfeeding Transmission in Malawi: Drug Concentrations, Virological Efficacy and Safety

L. Palombi, M. Giuliano, S. Vella, 2012, Antiviral therapy.

Levels of bone markers in a population of infants exposed in utero and during breastfeeding to tenofovir within an Option B+ programme in Malawi.

S. Mancinelli, L. Palombi, M. Giuliano, 2016, The Journal of antimicrobial chemotherapy.

Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under the Option B-Plus approach in Malawi.

S. Mancinelli, L. Palombi, M. Giuliano, 2016, The Journal of antimicrobial chemotherapy.

Development of a Human Immunodeficiency Virus Vector-Based, Single-Cycle Assay for Evaluation of Anti-Integrase Compounds

Y. Pommier, R. Di Santo, R. Costi, 2006, Antimicrobial Agents and Chemotherapy.

Limited Risk of Drug Resistance After Discontinuation of Antiretroviral Prophylaxis for the Prevention of Breastfeeding Transmission of HIV

L. Palombi, M. Giuliano, S. Vella, 2011, Journal of acquired immune deficiency syndromes.

Resistance mutation patterns in plasma and breast milk of HIV-infected women receiving highly-active antiretroviral therapy for mother-to-child transmission prevention.

S. Mancinelli, L. Palombi, M. Giuliano, 2007, AIDS.

Comparison of HIV type 1 sequences from plasma, cell-free breast milk, and cell-associated breast milk viral populations in treated and untreated women in Mozambique.

L. Palombi, M. Giuliano, S. Vella, 2009, AIDS research and human retroviruses.

Effects of raltegravir on 2-long terminal repeat circle junctions in HIV type 1 viremic and aviremic patients.

G. d’Ettorre, V. Vullo, P. Leone, 2013, AIDS research and human retroviruses.

Evaluation of HIV-1 integrase inhibitors on human primary macrophages using a luciferase-based single-cycle phenotypic assay.

Y. Pommier, V. Summa, R. Di Santo, 2010, Journal of Virological Methods.

Reconstitution of Intestinal CD 4 and Th 17 T Cells in Antiretroviral Therapy Suppressed HIV-Infected Subjects : Implication for Residual Immune Activation from the Results of a Clinical Trial

E. N. Cavallari, G. d’Ettorre, V. Vullo, 2022 .

Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy.

E. Nicastri, M. Andreoni, S. Vella, 1997, AIDS research and human retroviruses.

Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with <50copies/ml HIV-1 RNA.

L. Palmisano, M. Giuliano, S. Vella, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Determinants of Virologic and Immunologic Outcomes in Chronically HIV-Infected Subjects Undergoing Repeated Treatment Interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) Study

A. Monforte, L. Palmisano, F. Castelli, 2007, Journal of acquired immune deficiency syndromes.

Seroprevalence of Brucella Infection in a Cohort of HIV-Positive Malawian Pregnant Women Living in Urban Areas.

M. Giuliano, R. Luhanga, G. Liotta, 2022, Vector borne and zoonotic diseases.

Discordant response to antiretroviral therapy: HIV isolation, genotypic mutations, T-cell proliferation and cytokine production

G. d’Ettorre, V. Vullo, E. Nicastri, 2002, AIDS.

Virological Response and Drug Resistance 1 and 2 Years Post-Partum in HIV-Infected Women Initiated on Life-Long Antiretroviral Therapy in Malawi.

S. Mancinelli, L. Palombi, M. Giuliano, 2016, AIDS research and human retroviruses.

Drug resistance mutations 18 months after discontinuation of nevirapine-based ART for prevention of mother-to-child transmission of HIV in Malawi.

S. Mancinelli, L. Palombi, M. Giuliano, 2015, The Journal of antimicrobial chemotherapy.

Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral Treatment.

G. Guaraldi, E. Tamburrini, M. Floridia, 2015, AIDS research and human retroviruses.

Viro-immunological response and emergence of resistance in HIV-infected women receiving combination antiretroviral regimens for the prevention of mother-to-child transmission in Malawi.

S. Mancinelli, L. Palombi, M. Giuliano, 2014, The Journal of antimicrobial chemotherapy.

High Prevalence of M184 Mutation among Patients with Viroimmunologic Discordant Responses to Highly Active Antiretroviral Therapy and Outcomes after Change of Therapy Guided by Genotypic Analysis

Vincenzo Vullo, Loredana Sarmati, Stefano Vella, 2003, Journal of Clinical Microbiology.

HIV‐1 DNA dynamics and variations in HIV‐1 DNA protease and reverse transcriptase sequences in multidrug‐resistant patients during successful raltegravir‐based therapy

D. Francisci, O. Cirioni, A. Cara, 2016, Journal of medical virology.

Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL)

M. Gentile, D. Giannarelli, L. Trentin, 2020, Leukemia.

Transcriptome Profiling of Human Monocyte-Derived Macrophages Upon CCL2 Neutralization Reveals an Association Between Activation of Innate Immune Pathways and Restriction of HIV-1 Gene Expression

M. Pellegrini, L. Fantuzzi, K. Kaczor‐Urbanowicz, 2020, Frontiers in Immunology.

Selection of resistance mutations in children receiving prophylaxis with lamivudine or nevirapine for the prevention of postnatal transmission of HIV.

M. Giuliano, S. Vella, F. Mmiro, 2006, Journal of acquired immune deficiency syndromes.

Drug-Associated Resistance Mutations in Plasma and Peripheral Blood Mononuclear Cells of Human Immunodeficiency Virus Type 1-Infected Patients for Whom Highly Active Antiretroviral Therapy Is Failing

G. d’Ettorre, V. Vullo, E. Nicastri, 2003, Journal of Clinical Microbiology.

Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity.

M. Andreoni, H. Jacobsen, I. Duncan, 1996, Antiviral research.

The role of IL-15 in challenging Acquired Immunodeficiency Syndrome.

S. Stella, G. d’Ettorre, V. Vullo, 2012, Cytokine.

Deficit of IgG2 in HIV-positive pregnant women is responsible of inadequate IgG2 levels in their HIV-uninfected children in Malawi

S. Mancinelli, L. Palombi, M. Giuliano, 2018, Medical Microbiology and Immunology.

Nonnucleoside reverse transcriptase inhibitor concentrations during treatment interruptions and the emergence of resistance: a substudy of the ISS-PART Trial.

L. Palmisano, M. Giuliano, S. Vella, 2010, AIDS Research and Human Retroviruses.

Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis

G. d’Ettorre, V. Vullo, L. Palmisano, 2016, HIV clinical trials.

Rate and determinants of residual viremia in multidrug-experienced patients successfully treated with raltegravir-based regimens.

G. d’Ettorre, D. Francisci, D. Segala, 2015, AIDS research and human retroviruses.

Quality of life outcomes of combination zidovudine–didanosine–nevirapine and zidovudine–didanosine for antiretroviral-naive advanced HIV-infected patients

A. Wu, M. Mirra, C. Tomino, 2000, AIDS.

Immune Activation and Microbial Translocation Markers in HIV-Exposed Uninfected Malawian Infants in the First Year of Life.

L. Palmisano, S. Mancinelli, L. Palombi, 2019, Journal of tropical pediatrics.

Non-B HIV type 1 subtypes: replicative capacity and response to antiretroviral therapy.

G. d’Ettorre, V. Vullo, E. Nicastri, 2004, AIDS research and human retroviruses.

Soluble CD14 levels in plasma and breastmilk of Malawian HIV+ women: Lack of association with morbidity and mortality in their exposed infants

L. Palmisano, S. Mancinelli, L. Palombi, 2018, American journal of reproductive immunology.

HIV phenotype switching during antiretroviral therapy: emergence of saquinavir‐resistant strains with less cytopathogenicity

E. Nicastri, M. Andreoni, S. Vella, 1997, AIDS.

Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study

A. Frustaci, A. Tedeschi, M. Gentile, 2023, Cancers.

Rates of Seroprotection against Vaccine-Preventable Infectious Diseases in HIV-Exposed and -Unexposed Malawian Infants

M. Giuliano, R. Luhanga, S. Orlando, 2023, Pathogens.

Plasma viremia titration and RNA quantitation in ICD-p24 negative HIV type-1-infected patients.

C. Tomino, L. Sarmati, P. Iudicone, 1995, AIDS research and human retroviruses.

Saquinavir delays the emergence of zidovudine resistance in HIV‐1 seropositive patients treated with combination therapy

E. Nicastri, M. Andreoni, S. Vella, 1998, Journal of medical virology.

High rate of HIV isolation from plasma of asymptomatic patients through polyethylene glycol (PEG) treatment.

M. Andreoni, S. Parisi, S. Vella, 1994, Journal of Acquired Immune Deficiency Syndromes.

Selection of resistance mutations in pregnant women receiving zidovudine and lamivudine to prevent HIV perinatal transmission

M. Magoni, L. Palmisano, M. Giuliano, 2003, AIDS (London).

Viro-immunological response and emergence of resistance in HIV-infected women receiving combination antiretroviral regimens for the prevention of mother-to-child transmission in Malawi.

S. Mancinelli, L. Palombi, M. Giuliano, 2014, The Journal of antimicrobial chemotherapy.

Residual viraemia in subjects with chronic HIV infection and viral load < 50 copies/ml: the impact of highly active antiretroviral therapy

E. Nicastri, M. Andreoni, L. Palmisano, 2005, AIDS.

Micronutrient and Nutritional Status of HIV-Exposed and HIV-Unexposed Malawian Infants in the First Year of Life: Assessment of Ferritin, Vitamin A, and D Status and Its Association with Growth

M. Giuliano, R. Luhanga, S. Orlando, 2023, Nutrients.

Comparison of HIV type 1 sequences from plasma, cell-free breast milk, and cell-associated breast milk viral populations in treated and untreated women in Mozambique.

L. Palombi, M. Giuliano, S. Vella, 2009, AIDS research and human retroviruses.

Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors

G. d’Ettorre, V. Vullo, R. Bellagamba, 2012, International journal of STD & AIDS.

Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with <50copies/ml HIV-1 RNA.

L. Palmisano, M. Giuliano, S. Vella, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.